[go: up one dir, main page]

GR3030930T3 - Use of IL-4 and TNF for the preparation of a medicament for the treatment of tumour cells - Google Patents

Use of IL-4 and TNF for the preparation of a medicament for the treatment of tumour cells

Info

Publication number
GR3030930T3
GR3030930T3 GR990402011T GR990402011T GR3030930T3 GR 3030930 T3 GR3030930 T3 GR 3030930T3 GR 990402011 T GR990402011 T GR 990402011T GR 990402011 T GR990402011 T GR 990402011T GR 3030930 T3 GR3030930 T3 GR 3030930T3
Authority
GR
Greece
Prior art keywords
tnf
cells
composition
growth
human
Prior art date
Application number
GR990402011T
Other languages
English (en)
Inventor
Bharat Aggarwal
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of GR3030930T3 publication Critical patent/GR3030930T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Output Control And Ontrol Of Special Type Engine (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Liquid Crystal Substances (AREA)
GR990402011T 1990-10-01 1999-08-06 Use of IL-4 and TNF for the preparation of a medicament for the treatment of tumour cells GR3030930T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59097790A 1990-10-01 1990-10-01
PCT/US1991/007234 WO1992005805A1 (en) 1990-10-01 1991-10-01 Synergism of tnf and il-4

Publications (1)

Publication Number Publication Date
GR3030930T3 true GR3030930T3 (en) 1999-11-30

Family

ID=24364509

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990402011T GR3030930T3 (en) 1990-10-01 1999-08-06 Use of IL-4 and TNF for the preparation of a medicament for the treatment of tumour cells

Country Status (21)

Country Link
EP (1) EP0563060B1 (el)
JP (1) JP3226918B2 (el)
KR (1) KR100225322B1 (el)
CN (1) CN1053838C (el)
AT (1) ATE179617T1 (el)
AU (1) AU658588B2 (el)
CA (1) CA2092914C (el)
DE (1) DE69131202T2 (el)
DK (1) DK0563060T3 (el)
ES (1) ES2134200T3 (el)
FI (1) FI931426A7 (el)
GR (1) GR3030930T3 (el)
IE (1) IE913264A1 (el)
IL (1) IL99497A (el)
NO (1) NO931139L (el)
NZ (1) NZ239829A (el)
PT (1) PT99123B (el)
RU (1) RU2114633C1 (el)
SA (1) SA92120509B1 (el)
WO (1) WO1992005805A1 (el)
ZA (1) ZA917424B (el)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1299295A (en) * 1993-12-02 1995-06-19 President And Fellows Of Harvard College Improved efficacy of alpha-helical cytokines
US5679338A (en) * 1994-05-12 1997-10-21 Osteoarthritis Science, Inc. Use of IL-4 for inhibition of the breakdown of articular cartilage and other tissues
US6277368B1 (en) 1996-07-25 2001-08-21 The Regents Of The University Of California Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine
CN1100566C (zh) * 1998-08-26 2003-02-05 北京师范大学 含有钙调神经磷酸酶b亚基的药物组合物
ID30176A (id) * 1999-03-12 2001-11-08 Boehringer Ingelheim Pharma Senyawa-senyawa yang bermanfaat sebagai zat anti-inflamasi
UA71952C2 (en) * 1999-11-16 2005-01-17 Urea aromatic derivatives as antiinflammatory agents
RU2191586C1 (ru) * 2001-05-15 2002-10-27 Ростовский научно-исследовательский онкологический институт Способ лечения рака яичников
RU2201762C1 (ru) * 2001-10-09 2003-04-10 Свадовский Александр Игоревич Способ лечения внутримозговой опухоли головного мозга
DE10321725A1 (de) * 2003-05-14 2004-12-02 Mucos Pharma Gmbh & Co Enzymhaltige Zusammensetzungen, daraus hergestellte diätetische Lebensmittel und Arzneimittel und ihre Verwendung für medizinische Zwecke
RU2389502C2 (ru) * 2004-07-29 2010-05-20 Займодженетикс, Инк. Применение il-28 и il-29 для лечения карциномы и аутоиммунных нарушений
CN100482683C (zh) * 2005-06-09 2009-04-29 中国人民解放军军事医学科学院放射与辐射医学研究所 人富含甘氨酸蛋白的活性片段及其应用
CN113368219B (zh) * 2021-06-28 2024-05-10 广东工业大学 Globulol的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650674A (en) * 1984-07-05 1987-03-17 Genentech, Inc. Synergistic cytotoxic composition
US4770995A (en) 1985-08-29 1988-09-13 New York Blood Center, Inc Detection of the sensitivity of cells to the effects of tumor necrosis factor and lymphotoxin
US4962091A (en) * 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides

Also Published As

Publication number Publication date
CA2092914A1 (en) 1992-04-02
IL99497A0 (en) 1992-08-18
CN1053838C (zh) 2000-06-28
JPH06501704A (ja) 1994-02-24
WO1992005805A1 (en) 1992-04-16
CN1060788A (zh) 1992-05-06
AU658588B2 (en) 1995-04-27
EP0563060B1 (en) 1999-05-06
NO931139D0 (no) 1993-03-26
DE69131202D1 (de) 1999-06-10
AU8950891A (en) 1992-04-28
DE69131202T2 (de) 2000-01-05
SA92120509B1 (ar) 2005-11-23
FI931426L (fi) 1993-04-27
ES2134200T3 (es) 1999-10-01
NZ239829A (en) 1993-03-26
EP0563060A4 (fr) 1993-08-04
JP3226918B2 (ja) 2001-11-12
CA2092914C (en) 2002-12-03
FI931426A7 (fi) 1993-04-27
RU2114633C1 (ru) 1998-07-10
DK0563060T3 (da) 1999-11-08
PT99123B (pt) 1999-02-26
FI931426A0 (fi) 1993-03-30
EP0563060A1 (en) 1993-10-06
PT99123A (pt) 1992-08-31
NO931139L (no) 1993-05-05
IL99497A (en) 1997-03-18
KR100225322B1 (ko) 1999-10-15
IE913264A1 (en) 1992-04-08
ATE179617T1 (de) 1999-05-15
ZA917424B (en) 1992-05-27

Similar Documents

Publication Publication Date Title
GR3030930T3 (en) Use of IL-4 and TNF for the preparation of a medicament for the treatment of tumour cells
ZA97858B (en) Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant.
AU2941489A (en) Reduction of side effects of cancer therapy
PL331583A1 (en) Ligand affinite to tumour necrosis factor
AU628095B2 (en) Chelants possessing ortho ligating functionality and complexes thereof
RU93032615A (ru) Композиции для воздействия на опухолевые клетки, способ обработки опухолевых клеток
EP0281070A3 (en) Pharmaceutical composition for the treatment of cancer
IL99778A0 (en) Compositions for the treatment of cell proliferation disorders
GR3002779T3 (en) Compositions and the use of interleukin-2 and/or interferon-beta and tumour necrosis factor for combination therapy or in providing medicaments or formulations
IL84189A0 (en) Pharmaceutical compositions containing tumor necrosis factors and anti-inflammatory agents
TW263437B (el)
EP0338679A3 (en) Tumour necrosis factor in the treatment of bladder cancer
Mohr et al. Adjuvant therapy in melanoma
EP0280593A3 (en) Composition on the basis of an amino-acid and vitamins for use in cancer therapy
YU29903A (sh) Upotreba antiprogestina za indukciju apoptoze u ćeliji
DE69840451D1 (de) Interferon-immuntherapie mit niedriger dosis
ES8704903A1 (es) Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido.
KR0177821B1 (en) Pharmaceutical compositions containing 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans
AU645042B2 (en) Use of a polypeptide having the activity of gamma interferon for the preparation of pharmaceutical compositions intended for the treatment of primary cancers of the pleura
EP0039874A3 (en) Methoxsalen compositions and their preparation
Korovin Use of radiotherapy at treatment of skin melanoma metastases in lungs
Kulik et al. Results of Operative Treatment of Patients Suffering From Lung Cancer and Tumors of the Heart
AU2358788A (en) The use of GM-CSF in the treatment of a patient requiring high-dose chemo- or radiotherapy for cancer
ZA872562B (en) Combination therapy using interleukin-2 and/or interferon-beta and tumor necrosis factor
GB8818556D0 (en) Novel therapeutic immunoconjugates for use in treatment of cancer